{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:59:22Z","timestamp":1784098762867,"version":"3.55.0"},"reference-count":27,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,5,19]],"date-time":"2005-05-19T00:00:00Z","timestamp":1116460800000},"content-version":"vor","delay-in-days":1356,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet Radiology Ultrasound"],"published-print":{"date-parts":[[2001,9]]},"abstract":"<jats:p>Many hyperthyroid cats referred for thyroid imaging and<jats:sup>131<\/jats:sup>I therapy are concurrently or recently receiving antithyroid medications. The effect of the antithyroid drug, methimazole, on thyroid uptake of<jats:sup>99m<\/jats:sup>TcO4 and<jats:sup>123<\/jats:sup>I was evaluated in 8 normal cats. Quantitative analysis was used to determine the normal percent dose uptake of<jats:sup>99m<\/jats:sup>TcO4 and<jats:sup>123<\/jats:sup>I, the change in thyroid: salivary ratios (T:S) of<jats:sup>99m<\/jats:sup>TcO4 over time, and the duration of the methimazole effect on thyroid uptake of<jats:sup>123<\/jats:sup>I. Methimazole was administered to 5 cats for 3 weeks in which a hypothyroid state was obtained; 3 cats served as non\u2010treatment controls.<jats:sup>99m<\/jats:sup>TcO4 and 8 and 24 hour<jats:sup>123<\/jats:sup>I imaging was repeated after 3 weeks of methimazole therapy (time of maximum T4 suppression). Methimazole was then discontinued and<jats:sup>123<\/jats:sup>I images and serum T4 concentrations were repeated at 1, 4, 9, 15, and 24 days post withdrawal. The percent dose uptake of<jats:sup>99m<\/jats:sup>TcO4 increased throughout the acquisition period with maximum uptake occurring 4 hour post injection. The baseline 20 min. T:S ratio for controls and treatment cats were 0.79 \u00b1 0.08 and 0.81 \u00b1 0.05 respectively; with a peak value of 1.29 \u00b1 0.23 and 1.31 \u00b1 0.18 at 4 hours. The baseline T:S ratios were not significantly different from 20 minutes to 2 hours, however they were significantly elevated at 4 hours post injection. Baseline, 8 and 24 hour percent dose uptake of<jats:sup>123<\/jats:sup>I were 2.1 \u00b1 0.42% and 7.04 \u00b1 1.24%, respectively. There was a significant increase in the T:S ratio in the treatment group at all time points. The 8 hour percent dose uptake of<jats:sup>123<\/jats:sup>I at 1, 4, and 9 days post methimazole withdrawal were significantly increased and peaked at 4 days. The 24 hour uptake was significantly increased at 4 and 9 days, with peak uptake at 9 days post\u2010methimazole withdrawal. The<jats:sup>123<\/jats:sup>I percent dose uptake decreased to baseline values by day 15 post withdrawal. Radioiodine uptake is not inhibited by methimazole treatment in normal cats, and is significantly enhanced after recent withdrawal. This finding is supportive of a \u201cshort term rebund effect\u201d with maximal enhanced uptake between 4 and 9 days after discontinuing antithyroid drugs. The increased uptake of<jats:sup>99m<\/jats:sup>TcO4 may also affect the interpretation of<jats:sup>99m<\/jats:sup>TcO4 thyroid scintigraphy for 2\u20133 weeks.<\/jats:p>","DOI":"10.1111\/j.1740-8261.2001.tb00969.x","type":"journal-article","created":{"date-parts":[[2005,5,19]],"date-time":"2005-05-19T15:59:30Z","timestamp":1116518370000},"page":"448-457","source":"Crossref","is-referenced-by-count":39,"title":["THE EFFECT OF METHIMAZOLE ON THYROID UPTAKE OF PERTECHNETATE AND RADIOIODINE IN NORMAL CATS"],"prefix":"10.1111","volume":"42","author":[{"given":"Janet A.","family":"Nieckarz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory B.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,5,19]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"1053","article-title":"Diagnosis and Management of feline hyperthyroidism","volume":"11","author":"Meric SM.","year":"1989","journal-title":"Compend Contin Ed"},{"key":"e_1_2_1_3_2","first-page":"106","volume-title":"Handbook of Canine and Feline Endocrinology and Reproduction","author":"Feldman EC","year":"1987"},{"key":"e_1_2_1_4_2","first-page":"1026","volume-title":"Current Veterinary Therapy IX","author":"Peterson ME","year":"1986"},{"key":"e_1_2_1_5_2","first-page":"969","article-title":"The three therapeutic options for feline hyperthyroidism","volume":"84","author":"Meric SM.","year":"1989","journal-title":"Vet Med"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1740-8261.1984.tb00737.x"},{"key":"e_1_2_1_7_2","first-page":"359","article-title":"Thyroid carcinoma causing hyperthyroidism in cats: 14 cases (1981\u20131986)","volume":"193","author":"Turrel JM","year":"1988","journal-title":"J Am Med Assoc"},{"key":"e_1_2_1_8_2","first-page":"554","article-title":"Radioactive iodine therapy in cats with hyperthyroidism","volume":"184","author":"Turrel JM","year":"1984","journal-title":"J Am Vet Med Assoc"},{"key":"e_1_2_1_9_2","first-page":"1038","article-title":"Serum thyroxine concentrations after radioactive iodine therapy in cats with hyperthyroidism","volume":"188","author":"Meric SM","year":"1986","journal-title":"J Am Vet Med Assoc"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2460\/javma.1995.207.11.1422","article-title":"Radioiodine treatment of 524 cats with hyperthyroidism","volume":"207","author":"Peterson ME","year":"1995","journal-title":"J Am Vet Med Assoc"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1740-8261.1994.tb01594.x"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1988.tb02812.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/02841868109130191"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5167.151"},{"key":"e_1_2_1_15_2","article-title":"Radioiodine treatment outcome in hyperthyroid cats: Effect of prior methimazole treatment","author":"Smith TA","year":"1995","journal-title":"AC VIM abstract"},{"key":"e_1_2_1_16_2","volume-title":"Diagnostic nuclear medicine","author":"Becker DV","year":"1995"},{"key":"e_1_2_1_17_2","first-page":"193","article-title":"Predictive value of tracer studies for 131I treatment in hyperthyroid cats","volume":"49","author":"Broome MR","year":"1988","journal-title":"Am J Vet Res"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1740-8261.1992.tb00149.x"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1994.tb03238.x"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1740-8261.1997.tb00862.x"},{"key":"e_1_2_1_21_2","first-page":"587","volume-title":"Vet Clin North Am Small Anim Pract","author":"Kintzer PP","year":"1994"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1740-8261.1985.tb01113.x"},{"key":"e_1_2_1_23_2","volume-title":"Textbook of medical physiology","author":"Guyton AC.","year":"1991"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(60)90171-6"},{"key":"e_1_2_1_25_2","volume-title":"Clinical use of radioisotopes","author":"Beirwalters WH","year":"1957"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.2.685"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1995.5.7"},{"key":"e_1_2_1_28_2","first-page":"87","article-title":"Therapeutic 1\u2013131 dose in hyperthyroidism: role of pretreatment with thioamide","volume":"6","author":"Kabadi U","year":"1994","journal-title":"Thyroidology"}],"container-title":["Veterinary Radiology &amp; Ultrasound"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1740-8261.2001.tb00969.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1740-8261.2001.tb00969.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T01:28:10Z","timestamp":1706232490000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1740-8261.2001.tb00969.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1111\/j.1740-8261.2001.tb00969.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1740-8261.2001.tb00969.x","archive":["Portico"],"relation":{},"ISSN":["1058-8183","1740-8261"],"issn-type":[{"value":"1058-8183","type":"print"},{"value":"1740-8261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}